New York State Common Retirement Fund Sells 905 Shares of Envista Holdings Co. (NYSE:NVST)

New York State Common Retirement Fund decreased its position in Envista Holdings Co. (NYSE:NVST) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 416,246 shares of the company’s stock after selling 905 shares during the quarter. New York State Common Retirement Fund owned approximately 0.24% of Envista worth $8,029,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Envista in the 3rd quarter worth about $31,000. Huntington National Bank grew its holdings in Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after purchasing an additional 949 shares during the period. Venturi Wealth Management LLC increased its stake in shares of Envista by 528.4% during the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after purchasing an additional 1,638 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after purchasing an additional 728 shares in the last quarter.

Envista Price Performance

Shares of NVST opened at $20.68 on Wednesday. The company has a 50 day moving average of $20.18 and a two-hundred day moving average of $19.62. The company has a market cap of $3.56 billion, a price-to-earnings ratio of -3.19, a price-to-earnings-growth ratio of 1.27 and a beta of 1.34. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $23.00.

Envista (NYSE:NVST) last released its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. As a group, analysts predict that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

NVST has been the subject of several analyst reports. Leerink Partners upgraded Envista from an “underperform” rating to a “market perform” rating and raised their price target for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Wells Fargo & Company lifted their target price on shares of Envista from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, February 6th. Piper Sandler increased their price target on shares of Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 3rd. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. Finally, Morgan Stanley increased their target price on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Envista currently has an average rating of “Hold” and an average price target of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.